906 Leveraging CME to address social determinants of health in immunotherapy selection for advanced NSCLC: empowering clinicians for equitable care

906 Leveraging CME to address social determinants of health in immunotherapy selection for advanced NSCLC: empowering clinicians for equitable care

Bibliographic Details
Main Authors:	Kadrin Wilfong, Michael Beyer, Heather Drew
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

907 Enhancing multidisciplinary collaboration for effective integration of perioperative immunotherapies in stage I-III resectable NSCLC: a continuing medical education (CME) approach
by: Kadrin Wilfong, et al.
Published: (2023-11-01)

905 Moving from awareness to adoption: live virtual training equips community physicians to select first-line immunotherapy for advanced NSCLC
by: Kadrin Wilfong, et al.
Published: (2023-11-01)

Recent Advances in Immunotherapy in Metastatic NSCLC.
by: Pranshu Bansal, et al.
Published: (2016-11-01)

Empowering Rural-Remote Doctors Through Distance CME: a Literature Study
by: Kristian Wongso Giamto
Published: (2016-03-01)

Mechanism Based Quality Control (MBQC) of Herbal Products: A Case Study YIV-906 (PHY906)
by: Wing Lam, et al.
Published: (2018-11-01)

Equitable leadership on the ground: Converging on high-leverage practices
by: Mollie K. Galloway, et al.
Published: (2017-01-01)

Biomarkers for Immunotherapy in Driver-Gene-Negative Advanced NSCLC
by: Yiyi Huang, et al.
Published: (2023-09-01)

Collective Bargaining to Community Benefits: Leveraging Organized Labor to Advance an Equitable Clean Energy Transition
by: Oh, Sung Eun Sally
Published: (2024)

PB1735: ONLINE CME PROGRAM IMPROVED CLINICIANS’ ABILITY TO MANAGE PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA WITH ASPARAGINASE-BASED THERAPIES
by: Sarah Elizabeth Bomba, et al.
Published: (2023-08-01)

18.906 Algebraic Topology II, Spring 2006
by: Behrens, Mark
Published: (2020)

Directed evolution and immobilization of new lipase Lip 906
by: Dai Shuang, et al.
Published: (2021-01-01)

Emerging Biomarkers for the Selection of Advanced NSCLC-Affected Immunotherapy Patients
by: Luigi Della Gravara, et al.
Published: (2021-06-01)

Immunotherapy: From Advanced NSCLC to Early Stages, an Evolving Concept
by: Thierry Berghmans, et al.
Published: (2020-03-01)

Combined immunotherapy for advanced prostate cancer: Empowering the T cell army
by: Sufyan Suleman, et al.
Published: (2017-10-01)

CME Test
Published: (2023-01-01)

CME test
Published: (2023-01-01)

CME Test
Published: (2023-01-01)

CME Test
Published: (2017-12-01)

CME Test
Published: (2016-09-01)

CME Test
Published: (2018-01-01)

CME Test
Published: (2014-03-01)

CME test
Published: (2022-01-01)

CME Test
Published: (2022-01-01)

CME Test
Published: (2016-12-01)

CME Test
Published: (2016-03-01)

CME Test
Published: (2016-03-01)

CME Test
Published: (2017-09-01)

CME Test
Published: (2015-12-01)

CME Test
Published: (2016-06-01)

CME Test
Published: (2015-06-01)

CME Test
Published: (2014-12-01)

CME Test
Published: (2015-12-01)

CME Fund
by: Robert Matzdorff
Published: (2012-06-01)

CME Test
Published: (2014-06-01)

CME Test
Published: (2020-01-01)

The RSSA and CME
by: Jan Lotz
Published: (2011-05-01)

CME Test
Published: (2017-06-01)

CME Test
Published: (2019-01-01)

CME Test
Published: (2015-09-01)

CME Test
Published: (2017-06-01)